Paraneoplastic disorders of the memory and cognition

The Behavioral Neurology of Dementia

Volumn , Issue , 2009, Pages 377-394

  Bataller, Luis ^a   Dalmau, Josep ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950980110     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511581410.025     Document Type: Chapter

References (81)

1. Alamowitch, S., Graus, F., Uchuya, M. et al. (1997). Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 120, 923-928.
2. Albert, M. L., Darnell, J. C., Bender, A. et al. (1998). Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 11, 1321-1324.
3. Ances, B. M., Vitaliani, R., Taylor, R. A. et al. (2005). Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128, 1764-1777.
4. Antoine, J. C., Honnorat, J., Vocanson, C. et al. (1993). Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina. J Neurol Sci 117, 215-223.
5. Antoine, J. C., Honnorat, J., Camdessanche, J. P. et al. (2001). Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol 49, 214-221.
6. Aydiner, A., Gurvit, H. and Baral, I. (1998). Paraneoplastic limbic encephalitis with immature ovarian teratoma: a case report. J Neurooncol 37, 63-66.
7. Bakheit, A. M., Kennedy, P. G. and Behan, P. O. (1990). Paraneoplastic limbic encephalitis: clinico-pathological correlations. J NeurolNeurosurg Psychiatry 53, 1084-1088.
8. Bataller, L. and Dalmau, J. O. (2004). Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. Semin Neurol 24, 461-471.
9. Bataller, L., Graus, F., Saiz, A. and Vilchez, J. J. (2001). Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124, 437-443.
10. Bataller, L., Wade, D. F., Graus, F. et al. (2004). Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 62, 778-782.
11. Batchelor, T. T., Platten, M., Palmer-Toy, D. E. et al. (1998). Chorea as a paraneoplastic complication of Hodgkin’s disease. J Neurooncol 36, 185-190.
12. Bernal, F., Graus, F., Pifarre, A. et al. (2002). Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol 103, 509-515.
13. Brierley, J. B., Corsellis, J. A. N., Hierons, R. and Nevin, S. (1960). Subacute encephalitis of later adult life. Mainly affecting the limbic areas. Brain 83, 357-368.
14. Buckley, C., Oger, J., Clover, L. et al. (2001). Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50, 73-78.
15. Corsellis, J. A., Goldberg, G. J. and Norton, A. R. (1968). “Limbic encephalitis” and its association with carcinoma. Brain 91, 481-496.
16. Croteau, D., Owainati, A., Dalmau, J. and Rogers, L. R. (2001). Response to cancer therapy in a patient with a paraneoplastic choreiform disorder. Neurology 57, 719-722.
17. D’Avino, C., Lucchi, M., Ceravolo, R. et al. (2001). Limbic encephalitis associated with thymic cancer: a case report. J Neurol 248, 1000-1002.
18. Dalmau, J., Gleichman, A. J., Hughes, E. G. et al. (2008). Anti-NMDA receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7, 1091-1098.
19. Dalmau, J., Graus, F., Rosenblum, M. K. and Posner, J. B. (1992). Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 71, 59-72.
20. Dalmau, J, Gultekin, H. S. and Posner, J. B. (1999). A serologic marker of paraneoplastic limbic and brainstem encephalitis in patients with testicular cancer (letter). N Engl J Med 341, 1475-1476.
21. Dalmau, J., Graus, F., Villarejo, A. et al. (2004). Clinical analysis of anti-Ma2-associated encephalitis. Brain 127, 1831-1844.
22. Darnell, R. B. and Posner, J. B. (2003). Paraneoplastic syndromes involving the nervous system. N Engl J Med 349, 1543-1554.
23. Dirr, L. Y., Elster, A. D., Donofrio, P. D. and Smith, M. (1990). Evolution of brain MRI abnormalities in limbic encephalitis. Neurology 40, 1304-1306.
24. Dorresteijn, L. D., Kappelle, A. C., Renier, W. O. and Gijtenbeek, J. M. (2002). Anti-amphiphysin associated limbic encephalitis: a paraneoplastic presentation of small-cell lung carcinoma. J Neurol 249, 1307-1308.
25. Elrington, G. M., Murray, N. M., Spiro, S. G. and Newsom-Davis, J. (1991). Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 54, 764-767.
26. Fadare, O. and Hart, H. J. (2004). Anti-Ri antibodies associated with short-term memory deficits and a mature cystic teratoma of the ovary. Int Semin Surg Oncol 1, 11.
27. Fadul, C. E., Stommel, E. W., Dragnev, K. H., Eskey, C. J. and Dalmau, J. O. (2005). Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy. J Neurooncol 72, 195-198.
28. Fujii, N., Furuta, A., Yamaguchi, H., Nakanishi, K. and Iwaki, T. (2001). Limbic encephalitis associated with recurrent thymoma: a postmortem study. Neurology 57, 344-347.
29. Graus, F., Dalmau, J., Rene, R. et al. (1997). Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 15, 2866-2872.
30. Graus, F., Keime-Guibert, F., Rene, R. et al. (2001). Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124, 1138-1148.
31. Graus, F., Delattre, J. Y., Antoine, J. C. et al. (2004). Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75, 1135-1140.
32. Gultekin, S. H., Rosenfeld, M. R., Voltz, R. et al. (2000). Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123, 1481-1494.
33. Hammer, M. S., Larsen, M. B. and Stack, C. V. (1995). Outcome of children with opsoclonus-myoclonus regardless of etiology. Pediatr Neurol 13, 21-24.
34. Harloff, A., Hummel, S., Kleinschmidt, M. and Rauer, S. (2005). Anti-Ri antibodies and limbic encephalitis in a patient with carcinoid tumour of the lung. J Neurol 252, 1404-1405.
35. Hayward, K., Jeremy, R. J., Jenkins, S. et al. (2001). Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and antineuronal antibodies. J Pediatr 139, 552-559.
36. Jean, W.C., Dalmau, J., Ho, A. and Posner, J.B. (1994). Analysis of the IgGsubclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 44, 140-147.
37. Kassubek, J., Juengling, F. D., Nitzsche, E. U. and Lucking, C. H. (2001). Limbic encephalitis investigated by 18FDG-PET and 3D MRI. J Neuroimaging 11, 55-59.
38. Keime-Guibert, F., Graus, F., Broet, P. et al. (1999). Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 53, 1719-1723.
39. Koh, P. S., Raffensperger, J. G., Berry, S. et al. (1994). Longterm outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr 125, 712-716.
40. Lai, M., Hughes, E. G., Peng, X. et al. (2008). AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol in press.
41. Lawn, N. D., Westmoreland, B. F., Kiely, M. J., Lennon, V. A. and Vernino, S. (2003). Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 78, 1363-1368.
42. Lee, A. C., Ou, Y., Lee, W. K. and Wong, Y. C. (2003). Paraneoplastic limbic encephalitis masquerading as chronic behavioural disturbance in an adolescent girl. Acta Paediatr 92, 506-509.
43. Liguori, R., Vincent, A., Clover, L. et al. (2001). Morvan’s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124, 2417-2426.
44. Linke, R., Schroeder, M., Helmberger, T. and Voltz, R. (2004). Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology 63, 282-286.
45. Mitchell, W. G. and Snodgrass, S. R. (1990). Opsoclonusataxia due to childhood neural crest tumors: a chronic neurologic syndrome. J Child Neurol 5, 153-158.
46. Mitchell, W. G., Davalos-Gonzalez, Y. and Brumm, V. L. (2002). Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics 109, 86-98.
47. Muehlschlegel, S., Okun, M. S., Foote, K. D. et al. (2005). Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder. Mov Disord 20, 1523-1527.
48. Muller-Hermelink, H. K. and Marx, A. (2000). Thymoma. Curr Opin Oncol 12, 426-433.
49. Muni, R. H., Wennberg, R., Mikulis, D. J. and Wong, A. M. (2004). Bilateral horizontal gaze palsy in presumed paraneoplastic brainstem encephalitis associated with a benign ovarian teratoma. J Neuroophthalmol 24, 114-118.
50. Mut, M., Schiff, D. and Dalmau, J. (2005). Paraneoplastic recurrent multifocal encephalitis presenting with epilepsia partialis continua. J Neurooncol 72, 63-66.
51. Nokura, K., Yamamoto, H., Okawara, Y. et al. (1997). Reversible limbic encephalitis caused by ovarian teratoma. Acta Neurol Scand 95, 367-373.
52. North, K. N., Ouvrier, R. A., McLean, C. A. and Hopkins, I. J. (1994). Idiopathic hypothalamic dysfunction with dilated unresponsive pupils: report of two cases. J Child Neurol 9, 320-325.
53. Nunn, K., Ouvrier, R., Sprague, T., Arbuckle, S. and Docker, M. (1997). Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome? J Child Neurol 12, 276-281.
54. Nuti, A., Ceravolo, R., Salvetti, S. et al. (2000). Paraneoplastic choreic syndrome during non-Hodgkin’s lymphoma. Mov Disord 15, 350-352.
55. Okamura, H., Oomori, N. and Uchitomi, Y. (1997). An acutely confused 15-year-old girl. Lancet 350, 488.
56. Overeem, S., Dalmau, J., Bataller, L. et al. (2004). Anti-Ma2 antibodies in idiopathic and paraneoplastic hypocretindeficient narcolepsy. Neurology 62, 138-140.
57. Posner, J. B. (1995). Metabolic and nutritional complications of cancer. Neurologic Complications of Cancer, Ch. 11. Philaldelphia, PA: F. A. Davis, pp. 264-281.
58. Pozo-Rosich, P., Clover, L., Saiz, A., Vincent, A. and Graus, F. (2003). Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 54, 530-533.
59. Rojas, I., Graus, F., Keime-Guibert, F. et al. (2000). Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 55, 713-715.
60. Rosenfeld, M. R., Eichen, J. G., Wade, D. F., Posner, J. B. and Dalmau, J. (2001). Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol 50, 339-348.
61. Russo, C., Cohn, S. L., Petruzzi, M. J. and de Alarcon, P. A. (1997). Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol 28, 284-288.
62. Samii, A., Dahlen, D. D., Spence, A. M. et al. (2003). Paraneoplastic movement disorder in a patient with non-Hodgkin’s lymphoma and CRMP-5 autoantibody. Mov Disord 18, 1556-1558.
63. Scheid, R., Voltz, R., Guthke, T. et al. (2003). Neuropsychiatric findings in anti-Ma2-positive paraneoplastic limbic encephalitis. Neurology 61, 1159-1161.
64. Scheid, R., Lincke, T., Voltz, R., von Cramon, D. Y. and Sabri, O. (2004). Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol 61, 1785-1789.
65. Scheid, R., Voltz, R., Vetter, T., Sabri, O. and von Cramon, D. Y. (2005). Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses. J Neurol 252, 1129-1132.
66. Shavit, Y. B., Graus, F., Probst, A., Rene, R., and Steck, A. J. (1999). Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis. Ann Neurol 45, 255-258.
67. Sillevis, S. P., Grefkens, J., De Leeuw, B. et al. (2002). Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol 249, 745-753.
68. Sirvent, N., Berard, E., Chastagner, P. et al. (2003). Hypothalamic dysfunction associated with neuroblastoma: evidence for a new paraneoplastic syndrome? Med Pediatr Oncol 40, 326-328.
69. Stein-Wexler, R., Wootton-Gorges, S. L., Greco, C. M. and Brunberg, J. A. (2005). Paraneoplastic limbic encephalitis in a teenage girl with an immature ovarian teratoma. Pediatr Radiol 35, 694-697.
70. Stubgen, J. P. (1998). Nervous system lupus mimics limbic encephalitis. Lupus 7, 557-560.
71. Tanaka, K., Tanaka, M., Inuzuka, T., Nakano, R. and Tsuji, S. (1999). Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J Neurol Sci 163, 159-162.
72. Tani, T., Piao, Y., Mori, S. et al. (2000). Chorea resulting from paraneoplastic striatal encephalitis. J Neurol Neurosurg Psychiatry 69, 512-515.
73. Thieben, M. J., Lennon, V. A., Boeve, B. F. et al. (2004). Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62, 1177-1182.
74. Vernino, S., Tuite, P., Adler, C. H. et al. (2002). Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 51, 625-630.
75. Vernino, S., O’Neill, B. P., Marks, R. S., O’Fallon, J. R. and Kimmel, D. W. (2004). Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neurooncology 6, 55-62.
76. Vincent, A., Buckley, C., Schott, J. M. et al. (2004). Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127, 701-712.
77. Vitaliani, R., Mason, W., Ances, B. et al. (2005). Paraneoplastic encephalitis, psychiatric symptoms and central hypoventilation: association with teratoma and hippocampal antibodies. Ann Neurol 58, 594-604.
78. Voltz, R., Gultekin, S. H., Rosenfeld, M. R. et al. (1999). A serologic marker of paraneoplastic limbic and brainstem encephalitis in patients with testicular cancer. N Engl J Med 340, 1788-1795.
79. Yiu, V. W., Kovithavongs, T., McGonigle, L. F. and Ferreira, P. (2001). Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome. Pediat Neurol 24, 72-74.
80. Younes-Mhenni, S., Janier, M. F., Cinotti, L. et al. (2004). FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 127, 2331-2338.
81. Yu, Z., Kryzer, T. J., Griesmann, G. E. et al. (2001). CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49, 146-154.